Pfizer

News

Myocarditis case mars Sarepta DMD gene therapy readout

New data on Sarepta's gene therapy for Duchenne muscular dystrophy (DMD) has gone a long way towards building confidence in its efficacy – but have introduced a concern about its safety.

News

ResApp bags FDA okay for sleep apnoea app, after Pfizer take...

Pfizer is still waiting for the green light to complete an acquisition of digital health company ResApp, a deal that looks even better now that its smartphone app for people with obstructiv

News

FDA backs pharmacist prescribing of Paxlovid for COVID

Some patients with COVID-19 will be able to get easier access to Pfizer's oral antiviral therapy Paxlovid, after the FDA ruled that pharmacists would be able to prescribe the drug.

News

BioNTech bites back after CureVac patent challenge

BioNTech has responded to a patent infringement lawsuit filed by fellow German biotech CureVac over its COVID-19 vaccine, saying it will "vigorously" defend itself.

News

Sanofi makes low-cost medicines pledge for low-income countr...

Sanofi has said it will make 30 of its most commonly prescribed medicines available at non-profit prices to 40 lower-income countries, as part of a global health initiative launched by the

News

Pfizer claims new $3.2bn COVID jab deal with US government

Pfizer and BioNTech have signed a new $3.2 billion supply contract with the US government for COVID-19 vaccines, covering 105 million doses that may include Omicron-targeted shots.

Myocarditis case mars Sarepta DMD gene therapy readout

ResApp bags FDA okay for sleep apnoea app, after Pfizer take...

FDA backs pharmacist prescribing of Paxlovid for COVID

BioNTech bites back after CureVac patent challenge

Sanofi makes low-cost medicines pledge for low-income countr...

Pfizer claims new $3.2bn COVID jab deal with US government

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

Pfizer

Editor's Picks